U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H19N5O.H2O
Molecular Weight 387.4344
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GALUNISERTIB MONOHYDRATE

SMILES

O.CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(N)=O

InChI

InChIKey=UZOSBNQFZUJWFP-UHFFFAOYSA-N
InChI=1S/C22H19N5O.H2O/c1-13-4-2-5-18(25-13)21-20(19-6-3-11-27(19)26-21)15-9-10-24-17-8-7-14(22(23)28)12-16(15)17;/h2,4-5,7-10,12H,3,6,11H2,1H3,(H2,23,28);1H2

HIDE SMILES / InChI

Molecular Formula C22H19N5O
Molecular Weight 369.4192
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 15:49:43 UTC 2023
Edited
by admin
on Fri Dec 15 15:49:43 UTC 2023
Record UNII
338K210Q5W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GALUNISERTIB MONOHYDRATE
WHO-DD  
Common Name English
LY-2157299 MONOHYDRATE
Code English
Galunisertib monohydrate [WHO-DD]
Common Name English
6-QUINOLINECARBOXAMIDE, 4-(5,6-DIHYDRO-2-(6-METHYL-2-PYRIDINYL)-4H-PYRROLO(1,2-B)PYRAZOL-3-YL)-, HYDRATE (1:1)
Systematic Name English
Code System Code Type Description
CAS
924898-09-9
Created by admin on Fri Dec 15 15:49:43 UTC 2023 , Edited by admin on Fri Dec 15 15:49:43 UTC 2023
PRIMARY
FDA UNII
338K210Q5W
Created by admin on Fri Dec 15 15:49:43 UTC 2023 , Edited by admin on Fri Dec 15 15:49:43 UTC 2023
PRIMARY
EPA CompTox
DTXSID40239014
Created by admin on Fri Dec 15 15:49:43 UTC 2023 , Edited by admin on Fri Dec 15 15:49:43 UTC 2023
PRIMARY
PUBCHEM
15945857
Created by admin on Fri Dec 15 15:49:43 UTC 2023 , Edited by admin on Fri Dec 15 15:49:43 UTC 2023
PRIMARY
EU-Orphan Drug
EU/3/13/1120(POSITIVE)
Created by admin on Fri Dec 15 15:49:43 UTC 2023 , Edited by admin on Fri Dec 15 15:49:43 UTC 2023
PRIMARY Treatment of glioma. 4/26/2013 Positive
EU-Orphan Drug
EU/3/13/1109 (POSITIVE)
Created by admin on Fri Dec 15 15:49:43 UTC 2023 , Edited by admin on Fri Dec 15 15:49:43 UTC 2023
PRIMARY Treatment of hepatocellular carcinoma 12/3/2013 Positive
SMS_ID
100000181841
Created by admin on Fri Dec 15 15:49:43 UTC 2023 , Edited by admin on Fri Dec 15 15:49:43 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
ANHYDROUS->SOLVATE
Related Record Type Details
ACTIVE MOIETY